01 Company overview Identity and operating footprint
Suggest correction Company type Robot maker
Market segment Corporate
Stage Series E
Founders Not listed
Regions served North America
Countries deployed Not listed
Service footprint Not listed
Last reviewed 2026-07-05
MX Robot models Specifications remain vendor-claimed
Suggest correction Machine medical
NeuroBlate System DP Deployment log Announced and cited only
Suggest correction Announced Customer Site Country Count Evidence 2025-07-24 Medical College of Wisconsin hospital_neurosurgery US Not disclosed Announcement 2022-05-10 Washington University School of Medicine (WashU) clinical use — NCT05124912 Un Not disclosed Announcement 2022-05-10 UCLA Medical Center clinical use — NCT05124912 Un Not disclosed Announcement 2022-05-10 University of Chicago Medicine clinical use — NCT05124912 Un Not disclosed Announcement 2022-05-10 University of Maryland Medical Center clinical use — NCT05124912 Un Not disclosed Announcement 2022-05-10 Duke University Hospital clinical use — NCT05124912 Un Not disclosed Announcement 2022-05-10 Wake Forest Baptist Medical Center clinical use — NCT05124912 Un Not disclosed Announcement 2022-05-10 Kettering Health clinical use — NCT05124912 Un Not disclosed Announcement 2014-09-10 Cleveland Clinic hospital_neurosurgery US Not disclosed Announcement 2014-09-10 UC San Diego Health System hospital_neurosurgery US Not disclosed Announcement 2014-09-10 Yale New Haven Hospital hospital_neurosurgery US Not disclosed Announcement
CA Funding history Publicly announced rounds
Suggest correction Investors on record Madryn Asset Management Trinity Capital
TL Company timeline Milestones and announcements
Suggest correction 2025-10-01 Strategic collaboration with Symphony Robotics to launch AI-driven micro-robotic platform for laser ablation in the brain PR Newswire 2025-01-01 Raised $28M Series E to advance NeuroBlate technology and expand market reach GSM Edtech SC Source ledger 14 unique public sources
Suggest correction 01 Trinity Capital Inc. Provides $35 Million in Growth Capital to Monteris Medical PR Newswire · retrieved 2026-07-05
02 Monteris Medical raises $28M Series E for robotic neurosurgery tech GSM Edtech · retrieved 2026-07-05
03 SEC Form D: $13,700,000 sold of $13,700,000 offering SEC EDGAR · retrieved 2026-07-05
04 SEC Form D: $9,000,000 sold of $30,000,000 offering SEC EDGAR · retrieved 2026-07-05
05 SEC Form D: $2,500,000 sold of $6,136,275 offering SEC EDGAR · retrieved 2026-07-05
06 SEC Form D: $10,682,010 sold of $17,157,115 offering SEC EDGAR · retrieved 2026-07-05
07 SEC Form D: $26,579,945 sold of $26,579,945 offering SEC EDGAR · retrieved 2026-07-05
08 SEC Form D: $6,830,567 sold of $10,000,000 offering SEC EDGAR · retrieved 2026-07-05
09 SEC Form D: $16,900,851 sold of $25,050,000 offering SEC EDGAR · retrieved 2026-07-05
10 Impressive Milestone for Monteris Medical's NeuroBlate System Surgical Robotics Technology
11 Medical College of Wisconsin completes 100th Neuroblate procedure Monteris Medical (X) · retrieved 2026-07-28
12 REMASTer: REcurrent Brain Metastases After SRS Trial ClinicalTrials.gov · retrieved 2026-07-28
13 Monteris Medical Reaches Milestone For NeuroBlate System PR Newswire · retrieved 2026-07-05
14 Monteris Medical and Symphony Robotics Announce Strategic Collaboration to Launch AI-Driven Micro-Robotic Platform PR Newswire · retrieved 2026-07-05